Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung, Alagie Jassey, Ching Hsuan Liu, Chien Ju Lin, Chun Ching Lin, Shu Hui Wong, Jonathan Y. Wang, Ming Hong Yen, Liang Tzung Lin

Résultat de recherche: Comment/debateexamen par les pairs

Résumé

In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".

Langue d'origineEnglish
Numéro d'article154128
JournalPhytomedicine
Volume102
DOI
Statut de publicationPublished - juill. 20 2022

Note bibliographique

Publisher Copyright:
© 2022 Elsevier GmbH

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

PubMed: MeSH publication types

  • Published Erratum

Empreinte numérique

Plonger dans les sujets de recherche 'Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))'. Ensemble, ils forment une empreinte numérique unique.

Citer